Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes

BackgroundAlcohol-associated liver disease (ALD) is a chronic condition influenced by both genetic and environmental factors. While GWAS has identified ALD-related loci (PNPLA3, MBOAT7, TM6SF2), underlying genetic mechanisms and therapeutic targets remain unclear.MethodsThis study utilized the FinnG...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianchang Wang, Zhe Wang, Minzhe Hu, Fangfeng Liu, Zhengjian Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1623367/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849253618681643008
author Qianchang Wang
Zhe Wang
Minzhe Hu
Fangfeng Liu
Fangfeng Liu
Zhengjian Wang
author_facet Qianchang Wang
Zhe Wang
Minzhe Hu
Fangfeng Liu
Fangfeng Liu
Zhengjian Wang
author_sort Qianchang Wang
collection DOAJ
description BackgroundAlcohol-associated liver disease (ALD) is a chronic condition influenced by both genetic and environmental factors. While GWAS has identified ALD-related loci (PNPLA3, MBOAT7, TM6SF2), underlying genetic mechanisms and therapeutic targets remain unclear.MethodsThis study utilized the FinnGen R12 dataset (488,982 participants) and GTEx v8 eQTL data to perform a cross-tissue transcriptome-wide association study (TWAS) using UTMOST, with single-tissue validation via FUSION. Gene-level association analysis (MAGMA), Mendelian randomization (MR), and colocalization were applied to evaluate causal links. Functional significance was assessed through GeneMANIA, drug enrichment, and molecular docking analyses.ResultsThree ALD susceptibility genes—AFF1, C4orf36, and HSD17B13—were identified and validated. HSD17B13 may reduce ALD risk via lipid metabolism and redox balance, while AFF1 is implicated in transcription regulation. C4orf36 requires further study. Drug enrichment analysis highlighted AFF1 as a target for beta-D-allopyranose, dexbrompheniramine, and (+)-chelidonine, with molecular docking confirming strong binding potential.ConclusionThis study identifies AFF1, C4orf36, and HSD17B13 as ALD susceptibility genes, proposing AFF1 as a potential therapeutic target, paving the way for precision medicine in ALD, though further experimental validation is needed to establish their functional relevance.
format Article
id doaj-art-5a3dfc26eaaa4cd8a8461ebe902af593
institution Kabale University
issn 2296-858X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-5a3dfc26eaaa4cd8a8461ebe902af5932025-08-20T03:56:17ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-07-011210.3389/fmed.2025.16233671623367Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genesQianchang Wang0Zhe Wang1Minzhe Hu2Fangfeng Liu3Fangfeng Liu4Zhengjian Wang5Graduate School, Shandong First Medical University, Jinan, Shandong, ChinaGraduate School, Shandong First Medical University, Jinan, Shandong, ChinaGraduate School, Shandong First Medical University, Jinan, Shandong, ChinaGraduate School, Shandong First Medical University, Jinan, Shandong, ChinaShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaBackgroundAlcohol-associated liver disease (ALD) is a chronic condition influenced by both genetic and environmental factors. While GWAS has identified ALD-related loci (PNPLA3, MBOAT7, TM6SF2), underlying genetic mechanisms and therapeutic targets remain unclear.MethodsThis study utilized the FinnGen R12 dataset (488,982 participants) and GTEx v8 eQTL data to perform a cross-tissue transcriptome-wide association study (TWAS) using UTMOST, with single-tissue validation via FUSION. Gene-level association analysis (MAGMA), Mendelian randomization (MR), and colocalization were applied to evaluate causal links. Functional significance was assessed through GeneMANIA, drug enrichment, and molecular docking analyses.ResultsThree ALD susceptibility genes—AFF1, C4orf36, and HSD17B13—were identified and validated. HSD17B13 may reduce ALD risk via lipid metabolism and redox balance, while AFF1 is implicated in transcription regulation. C4orf36 requires further study. Drug enrichment analysis highlighted AFF1 as a target for beta-D-allopyranose, dexbrompheniramine, and (+)-chelidonine, with molecular docking confirming strong binding potential.ConclusionThis study identifies AFF1, C4orf36, and HSD17B13 as ALD susceptibility genes, proposing AFF1 as a potential therapeutic target, paving the way for precision medicine in ALD, though further experimental validation is needed to establish their functional relevance.https://www.frontiersin.org/articles/10.3389/fmed.2025.1623367/fullalcohol- associated liver disease (ALD)genome-wide association study (GWAS)transcriptome-wide association study (TWAS)multi-marker analysis of GenoMic annotation (MAGMA)Mendelian randomization (MR)drug enrichment analysis
spellingShingle Qianchang Wang
Zhe Wang
Minzhe Hu
Fangfeng Liu
Fangfeng Liu
Zhengjian Wang
Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
Frontiers in Medicine
alcohol- associated liver disease (ALD)
genome-wide association study (GWAS)
transcriptome-wide association study (TWAS)
multi-marker analysis of GenoMic annotation (MAGMA)
Mendelian randomization (MR)
drug enrichment analysis
title Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
title_full Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
title_fullStr Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
title_full_unstemmed Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
title_short Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes
title_sort genetic insights into alcohol associated liver disease integrative transcriptome wide analysis identifies novel susceptibility genes
topic alcohol- associated liver disease (ALD)
genome-wide association study (GWAS)
transcriptome-wide association study (TWAS)
multi-marker analysis of GenoMic annotation (MAGMA)
Mendelian randomization (MR)
drug enrichment analysis
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1623367/full
work_keys_str_mv AT qianchangwang geneticinsightsintoalcoholassociatedliverdiseaseintegrativetranscriptomewideanalysisidentifiesnovelsusceptibilitygenes
AT zhewang geneticinsightsintoalcoholassociatedliverdiseaseintegrativetranscriptomewideanalysisidentifiesnovelsusceptibilitygenes
AT minzhehu geneticinsightsintoalcoholassociatedliverdiseaseintegrativetranscriptomewideanalysisidentifiesnovelsusceptibilitygenes
AT fangfengliu geneticinsightsintoalcoholassociatedliverdiseaseintegrativetranscriptomewideanalysisidentifiesnovelsusceptibilitygenes
AT fangfengliu geneticinsightsintoalcoholassociatedliverdiseaseintegrativetranscriptomewideanalysisidentifiesnovelsusceptibilitygenes
AT zhengjianwang geneticinsightsintoalcoholassociatedliverdiseaseintegrativetranscriptomewideanalysisidentifiesnovelsusceptibilitygenes